294 related articles for article (PubMed ID: 12359775)
21. Extracellular cysteine/cystine redox regulates the p44/p42 MAPK pathway by metalloproteinase-dependent epidermal growth factor receptor signaling.
Nkabyo YS; Go YM; Ziegler TR; Jones DP
Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G70-8. PubMed ID: 15746213
[TBL] [Abstract][Full Text] [Related]
22. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
Ota H; Tokunaga E; Chang K; Hikasa M; Iijima K; Eto M; Kozaki K; Akishita M; Ouchi Y; Kaneki M
Oncogene; 2006 Jan; 25(2):176-85. PubMed ID: 16170353
[TBL] [Abstract][Full Text] [Related]
23. Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration.
Giehl K; Skripczynski B; Mansard A; Menke A; Gierschik P
Oncogene; 2000 Jun; 19(25):2930-42. PubMed ID: 10871844
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
26. Histamine stimulation of MMP-1(collagenase-1) secretion and gene expression in gastric epithelial cells: role of EGFR transactivation and the MAP kinase pathway.
Ancha HR; Kurella RR; Stewart CA; Damera G; Ceresa BP; Harty RF
Int J Biochem Cell Biol; 2007; 39(11):2143-52. PubMed ID: 17656145
[TBL] [Abstract][Full Text] [Related]
27. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP
Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204
[TBL] [Abstract][Full Text] [Related]
28. EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells.
Camaj P; Seeliger H; Ischenko I; Krebs S; Blum H; De Toni EN; Faktorova D; Jauch KW; Bruns CJ
Biol Chem; 2009 Dec; 390(12):1293-302. PubMed ID: 19804359
[TBL] [Abstract][Full Text] [Related]
29. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
Grant SL; Hammacher A; Douglas AM; Goss GA; Mansfield RK; Heath JK; Begley CG
Oncogene; 2002 Jan; 21(3):460-74. PubMed ID: 11821958
[TBL] [Abstract][Full Text] [Related]
30. The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines.
Tsang DK; Crowe DL
Int J Oncol; 1999 Sep; 15(3):519-23. PubMed ID: 10427134
[TBL] [Abstract][Full Text] [Related]
31. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
Gardner DP; Shimizu N
J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor efficiently activates mitogen-activated protein kinase in HeLa cells and Hep2 cells conditionally defective in clathrin-dependent endocytosis.
Johannessen LE; Ringerike T; Molnes J; Madshus IH
Exp Cell Res; 2000 Oct; 260(1):136-45. PubMed ID: 11010818
[TBL] [Abstract][Full Text] [Related]
33. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses.
Starbuck C; Lauffenburger DA
Biotechnol Prog; 1992; 8(2):132-43. PubMed ID: 1368006
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy.
Pai R; Soreghan B; Szabo IL; Pavelka M; Baatar D; Tarnawski AS
Nat Med; 2002 Mar; 8(3):289-93. PubMed ID: 11875501
[TBL] [Abstract][Full Text] [Related]
35. Peptide YY Y1 receptor activates mitogen-activated protein kinase and proliferation in gut epithelial cells via the epidermal growth factor receptor.
Mannon PJ; Mele JM
Biochem J; 2000 Sep; 350 Pt 3(Pt 3):655-61. PubMed ID: 10970776
[TBL] [Abstract][Full Text] [Related]
36. Anti-epidermal growth factor receptor monoclonal antibodies affecting signal transduction.
Reins HA; Steinhilber G; Freiberg B; Anderer FA
J Cell Biochem; 1993 Feb; 51(2):236-48. PubMed ID: 8382707
[TBL] [Abstract][Full Text] [Related]
37. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells.
Kawaguchi M; Hosotani R; Kogire M; Ida J; Doi R; Koshiba T; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Masui T; Imamura M
Int J Oncol; 2000 Jan; 16(1):37-41. PubMed ID: 10601546
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
[TBL] [Abstract][Full Text] [Related]
39. Effects of antisense epidermal growth factor and its receptor retroviral expression vectors on cell growth of human pancreatic carcinoma cell line.
Liu T; Chen J; Zeng C
Chin Med J (Engl); 1995 Sep; 108(9):653-9. PubMed ID: 8575229
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.
Simpson BJ; Bartlett JM; Macleod KG; Rabiasz G; Miller EP; Rae AL; Gordge P; Leake RE; Miller WR; Smyth J; Langdon SP
Br J Cancer; 1999 Mar; 79(7-8):1098-103. PubMed ID: 10098742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
